A novel sulfamethoxazole derivative as an inhibitory agent against HSP70: A combination of computational with in vitro studies
Introduction
Sulfonamides or sulfa-drugs are key motifs in pharmaceuticals that have drastically influenced the pharmacological markets in the recent century [1]. They are composed of a sulfur atom that has two sets of double bonds to two oxygen atoms, a carbon-based side group, and a nitrogen atom bonded to the sulfur itself [2]. The formation of hydrogen bonds in sulfonamides increases both their solubility and their ability to interact with their targets [3]. Several types of sulfonamides include phenolic sulfonamides [4], hetaryl sulfonamides [5], benzenesulfonamides [6], sulfonamide-containing pyrazoles [7], et cetera and there is a plethora of applications for sulfa-drugs in medicinal chemistry. Sulfonamide-based compounds are heterocyclic molecules that have exhibited several biological activities including their role as antibacterial [8], antifungal [9], anti-inflammatory [10], carbonic anhydrase inhibitors [11], lactoperoxidase inhibitors [12], acetylcholinesterase inhibitors [13], and anticancer agents [14]. Sulfonamide derivatives can act as anticancer agents through multiple mechanisms such as inhibition of tubulin polymerization [15], PI3K [16], Cox-2 [17], Akt [18], histone deacetylase [19], and NADPH reductase [20]. Sulfamethoxazole is an aminobenzene sulfonamide bacteriostatic antibiotic that is frequently used in combination with trimethoprim as the drug Bactrim [21]. Sulfamethoxazole competitively inhibits dihydropteroate synthase preventing the formation of dihydropteroic acid, a precursor of folic acid which is required for bacterial growth [22].
Mammalian heat shock proteins (HSPs) are a family of proteins, traditionally known as molecular chaperones, that can reverse or inhibit the denaturation of cellular proteins in response to cellular stress such as high temperature [23]. HSPs are sorted into several classes according to their monomeric molecular mass: First group includes HSP110, HSP100, HSP90, HSP70, and HSP60 which are ATP-dependent and are referred to as high molecular weight HSPs. The other group which is called low molecular weight HSPs has a molecular weight of 34 kDa or less and act in an ATP-independent manner [24], [25]. HSP70 is a member of the molecular chaperone family that is found in every membranous organelle of nearly all cells. The expression of HSP70 is usually kept at low levels under physiological conditions but is induced in protein-damaging situations such as heat shock, oxidative stress, hypoxia or heavy metals in order to provide resistance to proteotoxic stresses [26]. The main roles of HSP70 include protein folding as well as disaggregation and degradation of misfolded proteins. The HSP70 proteins contain two major functional domains: N-terminal nucleotide-binding domain (NBD) (45-kDa) and C-terminal substrate-binding domain (SBD) (25-kDa) [27], [28]. The binding of ATP to its corresponding domain facilitates the binding and releasing of protein substrate to HSP70 [29]. The presence of HSP40 proteins (also referred to as DnaJ or J-domain proteins) is necessary for the function of HSP70 since they stimulate the ATPase activity of HSP70 through their J-domain and also bind to non-native proteins with the purpose of presenting them to HSP70 [30]. The function of HSP70 has been linked to neurodegenerative diseases (e.g. Alzheimer's disease) and various types of cancers [31], [32]. Overexpression of HSP70 leads to an increase in resistance against apoptosis-inducing drugs such as imatinib, and doxorubicin and therefore, is associated with cancer [33], [34]. Moreover, HSP70 has also been shown to be able to reduce radiation sensitivity in tumor cells [35] and its phosphorylation may increase the resistance of tumor cells against methotrexate [36]. On the other hand, down-regulation of HSP70 increases the vulnerability of tumor cells to apoptosis [37]. Thus, HSP70 is an anti-apoptotic protein that can block both the extrinsic (death receptor) and intrinsic (mitochondria-dependent) pathways of apoptosis [38].
Highly-expressed HSP70 can interfere at three levels in apoptotic signaling: upstream to mitochondria, at the mitochondria, and post-mitochondria [39]. Release of cytochrome c from intermembrane space of mitochondria via apoptotic signals induces the ATP-dependent formation of Apaf-1-caspase-9 apoptosome which in turn activates caspase-9 [40], [41]. HSP70 can block the release of cytochrome c by preventing the translocation of Bid and Bax to the mitochondria [42]. HSP70 is also able to directly bind to Apaf-1, thereby hindering the activation of procaspase-9 [43]. Moreover, it has been indicated that the interaction of HSP70 with procaspase-7 and -9 suppresses their proteolysis [44]. Apart from caspase-dependent apoptosis, HSP70 can also associate with apoptosis-inducing factors and block AIF nuclear translocation which results in AIF-induced chromatin condensation [45].
Several reasons have made HSP70 become a well-liked target for drug discovery for various types of cancer. These include the predescribed importance of HSP70 dysregulation in cancer, the abundance of HSP70 family in almost every human tissues [26], the existence of various isoforms of HSP70 in human's genome [46], and similarity of structural domains in HSP70 isoforms [47] and according to these basis, several strategies have been proposed in order to inhibit the function of HSP70 [48], [49]. The first attempt was approached by Hosokawa et al. via the inhibition of the transcriptional factor of HSP70, HSF1 [50]. Another procedure described by Guo et al. was to knockdown HSP70 gene using siRNAs [51] but HSP70 itself has two potential inhibitor-binding sites based on its structure: the ATP binding site and the substrate-binding cleft [52]. 2-Phenylethynesulfonamide (also known as pifithrin-μ) and AEAC (a synthetic derivative of colchicine) are among small molecules that bind to the substrate-binding domain [53], [54] whereas apoptozole and artesunate can bind to the ATPase domain [48], [55].
Studying the inhibitory effects of apoptosis-inducing compounds on HSP70 activity is not plain and demands laboratory approaches such as X-ray crystallography, fluorescence polarization, and surface plasmon resonance [56]. Despite the high sensitivity of these techniques, they are costly and time-consuming due to long sample preparation steps before analysis. Hence, providing an accelerated, sensitive, and inexpensive method for screening apoptosis inducers based on inhibition of HSP70 is pivotal. Cell lysis and total protein extraction are considered the main parts for most of the techniques in order to study the chaperone activity of proteins [57]. To tackle this issue, in 1993 Schröder, et al. employed an approach for real-time analysis of intracellular proteins based on a co-expression system made up of a chaperone and a reporter gene in Escherichia coli [58]. Later, a hypothesis for the role of HSPs in protecting reporter proteins was put forward by Forreiter, et al. in 1997 [59]. In a real-time reporter system, luciferase is a promising candidate as an intracellular reporter in a bioluminescence assay due to the reproducibility, rapidity, and sensitivity of the assay and the lack of a physiological role for luciferase in E. coli metabolism [60]. Recently, for the first time, a real-time reporter system has been introduced for screening apoptosis-inducing compounds in E. coli cells based on inhibition of the activity of Hsp70 [57].
Carbonic anhydrases (CAs), are a class of proteins capable of catalyzing the hydration of carbon dioxide to bicarbonate and protons: CO2 + H2O ↔ HCO3- + H+ [61]. It has been shown that HSP70 can proceed with the folding process of CAs through their chaperone activity [55]. Protonography is a new derivative method of zymography, based on the activity of CA on SDS-PAGE gel. The produced protons through the function of CA are responsible for the change of the color which appears on the gel in the corresponding band. The boldest advantage of this technique is that based on the molecular weight markers, the activity of CAs with different molecular weights can be detected and quantified rapidly on a single gel [62], [63]. So far, protonography has been employed for a variety of uses related to different classes and isoforms of CA. These include analyzing the enzymatic activity of mammalian CA, α-CA, η-CA, and ɩ-CA on the protonogram [62], [64], [65], studying the oligomeric state of γ-CA (from Porphyromonas gingivalis) [66], investigating the inhibitory activity of inorganic anions against α-CA (from Corallium rubrum) [63], and studying the efficiency of sulfonamide derivatives against α-CA, β-CA, γ-CA, and ɩ-CA [67], [68], [69]. Since HSP70 can facilitate the folding process of CA, inhibition of HSP70 suppresses the progress of CA folding which can consequently be measured by protonography. In the present study, we have examined the effect of a novel sulfonamide derivative on HSP70 activity through a new protonography based method. In this study a sulfamethoxazole derivative called ZM-093 with IUPAC name of (E)-4-((4-(bis(2-hydroxyethyl)amino)phenyl)diazenyl)-N-(5-methylisoxazole-3-yl)benzenesulfonamide was synthesized, evaluated, computationally analyzed and its effect on the chaperone activity of HSP70 was assessed.
Section snippets
The general procedure for the synthesis of ZM-093
ZM-093 (Sulfamethoxazole-based azo dye) was prepared in high yield via common diazotization-coupling reactions. The diazonium salt was prepared from an equimolar mixture of sulfonamide derivative (2 mmol of sulfonamide derivative, 4 mL acetonitrile, and some drops of acetic acid) and in situ prepared HNO2 (NaNO2 & HCl). Then, to a solution containing coupling reagent (N-phenyl-2,2′-imino diethanol in ethanol), diazonium salt from the previous step was added dropwise. The resulting solution was
Molecular structure and geometry optimization of ZM-093
The novel sulfamethoxazole compound, ZM-093, was synthesized by the diazotizing-coupling method, where the diazonium component was acquired from bioactive sulfonamide derivative. Spectroscopic techniques, FT-IR, 1H NMR, and 13C NMR were employed in order to analyze the structural properties of the prepared dye. In the 1H NMR spectrum of ZM-093, two broad signals at the frequencies of 1.42 ppm and 10.66 ppm appeared as the characteristics of the methyl group of the sulfamethoxazole component and
Discussion
To begin with, sulfonamide (SO2-NH) is a famous functional group available in a variety of drugs and inhibitors with different applications in the world of pharmacology [88]. Subsequently, sulfamethoxazole is a sulfonamide-containing anti-biotic capable of inhibiting dihydropteroate synthase, therefore preventing nucleic acid synthesis [89]. In the recent century, Sulfonamides have gained a significant amount of importance due to their wide range of biological applications in the world of
Credit authorship contribution statement
Vaha Akbary Moghaddam and Vesal Kasmaeifar: Conceptualization, Methodology, Software. Zainab Mahmoodi: Data curation, Writing-Original draft preparation. Hossein Ghafouri: Supervision, Writing- Reviewing and Editing, Omid Saberi: Validation, Asadollah Mohammadi: Visualization, Investigation.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgement
The authors thank the Research Council of University of Guilan for the financial support to this study.
References (98)
- et al.
Carbonic anhydrase inhibitory properties of phenolic sulfonamides derived from dopamine related compounds
Arab. J. Chem.
(2017) - et al.
Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors
Bioorg. Chem.
(2019) - et al.
Inhibitors of the acetyltransferase domain of N -acetylglucosamine-1-phos- Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides
Bioorg. Med. Chem. Lett.
(2012) - et al.
The extremo-a-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides
Bioorganic Med. Chem.
(2013) - et al.
Synthesis, characterization, biological evaluation, and kinetic study of indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent
J. King Saud Univ. - Sci.
(2021) - et al.
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents
Comput. Biol. Chem.
(2018) - et al.
Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474
Bioorganic Med. Chem.
(2019) - et al.
Discovery of novel sulfonamide-containing aminophosphonate derivatives as selective COX-2 inhibitors and anti-tumor candidates
Bioorg. Chem.
(2020) - et al.
Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling
Eur. J. Med. Chem.
(2014) - et al.
Heat shock proteins and cancer
Trends Pharmacol. Sci.
(2017)
Using single-molecule approaches to understand the molecular mechanisms of heat-shock protein chaperone function
J. Mol. Biol.
Molecular cloning, prokaryotic expression, purification, structural studies and functional implications of Heat Shock Protein 70 (Hsp70) from Rutilus frisii kutum
Int. J. Biol. Macromol.
How Hsp70 molecular machines interact with their substrates to mediate diverse physiological functions
J. Mol. Biol.
Targeting HSP70 for cancer therapy
Mol. Cell
Targeting Hsp70: a possible therapy for cancer
Cancer Lett.
A small molecule inhibitor of ATPase activity of HSP70 induces apoptosis and has antitumor activities
Chem. Biol.
Inhibition of HSP70: a challenging anti-cancer strategy
Cancer Lett.
Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells
Int. J. Biol. Macromol.
Protonography and anion inhibition profile of the a-carbonic anhydrase (CruCA4) identified in the Mediterranean red coral Corallium rubrum
Bioorg. Chem.
Protonography, a powerful tool for analyzing the activity and the oligomeric state of the γ-carbonic anhydrase identified in the genome of Porphyromonas gingivalis
Bioorganic Med. Chem.
Comparison of the sulfonamide inhibition profiles of the a-, ß- And γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Bioorganic Med. Chem. Lett.
Novel push-pull heterocyclic azo disperse dyes containing piperazine moiety: Synthesis, spectral properties, antioxidant activity and dyeing performance on polyester fibers
Spectrochim. Acta A Mol. Biomol. Spectrosc.
Carbon materials with controlled edge structures
J. Mol. Graph.
Exploring the organic-inorganic interface with a scanning tunneling microscope
Encycl. Interfacial Chem. Surf. Sci Electrochem.
A comparative analysis of the electrophilicity of organic molecules between the computed IPs and EAs and the HOMO and LUMO energies
Chem. Phys. Lett.
Intermolecular reactivity through the generalized philicity concept
Chem. Phys. Lett.
Synthesis, characterization and computational study of the newly synthetized sulfonamide molecule
J. Mol. Struct.
Lead- and drug-like compounds: the rule-of-five revolution
Drug Discov. Today Technol.
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold
Bioorganic Med. Chem. Lett.
Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons
Neuropharmacology
Synthesis, characterization and biological investigation of glycine-based sulfonamide derivative and its complex: vibration assignment, HOMO – LUMO analysis, MEP and molecular docking
J. Mol. Struct.
Synthesis, antioxidant, and antiacetylcholinesterase activities of sulfonamide derivatives of dopamine-related compounds
Arch. Pharm. (Weinheim)
Sulfonamide molecular crystals: structure, sublimation thermodynamic characteristics, molecular packing, hydrogen bonds networks
Cryst. Growth Des.
Special issue: sulfonamides
Molecules
Synthesis and bioactivity of several new hetaryl sulfonamides
J. Enzyme Inhib. Med. Chem.
Synthesis, structure and evaluation of the N-(2-Acetyl-4-(styryl)phenyl)-4-benzenesulfonamide derivatives for anticholinesterase and antioxidant activities
Crystals.
In vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species
Jpn. J. Med. Mycol.
Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents
Med. Res. Rev.
Secondary sulfonamides as effective lactoperoxidase inhibitors
Molecules
Anticancer sulfonamide hybrids that inhibit bladder cancer cells growth and migration as tubulin polymerisation inhibitors
J. Enzyme Inhib. Med. Chem.
Recent progress in the discovery of Akt inhibitors as anticancer agents
Expert Opin. Ther. Pat.
Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents
Expert Opin. Ther. Pat.
Considerations when prescribing trimethoprim-sulfamethoxazole
CMAJ
Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole
Am. J. Trop. Med. Hyg.
Structure and mechanism of the Hsp90 molecular chaperone machinery
Annu. Rev. Biochem.
Hsp70 in cancer: back to the future
Oncogene
Hsp70 chaperone: a master player in protein homeostasis [version 1; peer review: 3 approved]
F1000Research
Structural basis for client recognition and activity of Hsp40 chaperones
Science (80-. )
The Hsp70/Hsp90 chaperone machinery in neurodegenerative diseases
Front. Neurosci.
Cited by (7)
Enhancing resistance and cell survival in Acipenser ruthenus liver, gill, and kidney cells: The potential of heat shock protein inducers against PAH-benzo[a]pyrene stress
2024, Environmental Science and Pollution ResearchRecent progress in the synthesis of N-substituted arylamines by reductive cross-coupling of nitroarenes
2024, Organic Chemistry Frontiers
- 1
These authors contributed equally to this work (co-first author).